However, CIDP with MN was occasionally seen in younger people (< 30 years) and had a more favorable response to immunotherapies compared with anti-CNTN1 antibody-positive CIDP. The gene discussed is CNTN1; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.